IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 118 filers reported holding IMMUNOVANT INC in Q2 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $8,678,149 | +12.2% | 457,467 | +5.0% | 0.03% | 0.0% |
| Q4 2022 | $7,734,580 | -29.5% | 435,751 | -77.9% | 0.03% | -40.9% |
| Q3 2022 | $10,978,000 | +333.7% | 1,967,300 | +328.3% | 0.04% | +340.0% |
| Q1 2022 | $2,531,000 | -67.0% | 459,300 | -49.0% | 0.01% | -67.7% |
| Q4 2021 | $7,672,000 | +154.5% | 900,500 | +379.2% | 0.03% | +121.4% |
| Q1 2021 | $3,014,000 | -74.7% | 187,900 | -27.3% | 0.01% | -75.9% |
| Q4 2020 | $11,935,000 | -77.6% | 258,400 | -82.9% | 0.06% | -78.8% |
| Q3 2020 | $53,252,000 | +1361.4% | 1,513,266 | +911.3% | 0.27% | +1037.5% |
| Q2 2020 | $3,644,000 | +901.1% | 149,643 | +539.7% | 0.02% | +700.0% |
| Q1 2020 | $364,000 | – | 23,392 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 4,448,017 | $17,347,000 | 4.39% |
| Deep Track Capital, LP | 9,455,000 | $36,875,000 | 2.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233 | $60,000,000 | 0.63% |
| Octagon Capital Advisors LP | 579,061 | $2,258,000 | 0.60% |
| Eventide Asset Management | 5,372,512 | $20,953,000 | 0.45% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 174,000 | $679,000 | 0.29% |
| Frazier Life Sciences Management, L.P. | 585,759 | $2,284,000 | 0.22% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $212,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 777,590 | $3,033,000 | 0.12% |
| Bridgefront Capital, LLC | 15,649 | $61,000 | 0.07% |